A detailed history of Pathstone Holdings, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pathstone Holdings, LLC holds 97,072 shares of LLY stock, worth $72.6 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
97,072
Previous 100,174 3.1%
Holding current value
$72.6 Million
Previous $90.7 Million 5.18%
% of portfolio
0.39%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $2.4 Million - $2.98 Million
-3,102 Reduced 3.1%
97,072 $86 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $1.36 Million - $1.71 Million
1,881 Added 1.91%
100,174 $90.7 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $65,142 - $87,150
110 Added 0.11%
98,293 $76.5 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $51.6 Million - $60.8 Million
98,183 New
98,183 $57.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.